This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2008 Nov 25;71(22):1833-4.

doi: 10.1212/01.wnl.0000339380.23073.58.

4-aminopyridine toxicity with unintentional overdose in four patients with multiple sclerosis

Jodie M Burton¹, Chaim M Bell, Scott E Walker, Paul W O'Connor

Affiliations

PMID: 19029525
DOI: 10.1212/01.wnl.0000339380.23073.58

4-aminopyridine toxicity with unintentional overdose in four patients with multiple sclerosis

Jodie M Burton et al. Neurology. 2008.

. 2008 Nov 25;71(22):1833-4.

doi: 10.1212/01.wnl.0000339380.23073.58.

Authors

Jodie M Burton¹, Chaim M Bell, Scott E Walker, Paul W O'Connor

Affiliation

¹ Division of Neurology, St. Michael's Hospital, 30 Bond St., Toronto, Ontario, M5B 1W8, Canada. burtonj@smh.toronto.on.ca

PMID: 19029525
DOI: 10.1212/01.wnl.0000339380.23073.58

No abstract available

PubMed Disclaimer

Comment in

News on treatment: from antiepileptics in childhood absence epilepsy to improvement of falls in Parkinson's disease by deep brain stimulation.
Strupp M. Strupp M. J Neurol. 2010 Apr;257(4):683-5. doi: 10.1007/s00415-010-5541-4. J Neurol. 2010. PMID: 20300764 No abstract available.

Similar articles

Status epilepticus associated with dalfampridine in a patient with multiple sclerosis.
de Gusmao CM, Ortega MR, Wallace DM. de Gusmao CM, et al. J Neuropsychiatry Clin Neurosci. 2012 Fall;24(4):E47-8. doi: 10.1176/appi.neuropsych.11110338. J Neuropsychiatry Clin Neurosci. 2012. PMID: 23224484 No abstract available.
An unusual case of 4-aminopyridine toxicity in a multiple sclerosis patient: epileptic disorder or toxic encephalopathy?
De Cauwer H, De Wolf P, Couvreur F, Mortelmans L. De Cauwer H, et al. Acta Neurol Belg. 2009 Mar;109(1):40-1. Acta Neurol Belg. 2009. PMID: 19402572
Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: a Phase I-II, open-label trial.
Vollmer T, Henney HR 3rd. Vollmer T, et al. Clin Ther. 2009 Oct;31(10):2206-14. doi: 10.1016/j.clinthera.2009.10.008. Clin Ther. 2009. PMID: 19922891 Clinical Trial.
Prolonged-release fampridine improves walking in a proportion of patients with multiple sclerosis.
Mathiesen HK, Sorensen PS. Mathiesen HK, et al. Expert Rev Neurother. 2013 Dec;13(12):1309-17. doi: 10.1586/14737175.2013.859523. Expert Rev Neurother. 2013. PMID: 24236901 Review.
Sustained-release fampridine for symptomatic treatment of multiple sclerosis.
Korenke AR, Rivey MP, Allington DR. Korenke AR, et al. Ann Pharmacother. 2008 Oct;42(10):1458-65. doi: 10.1345/aph.1L028. Epub 2008 Sep 9. Ann Pharmacother. 2008. PMID: 18780812 Review.

See all similar articles

Cited by

Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.
Staes C, Jacobs J, Mayer J, Allen J. Staes C, et al. Am J Health Syst Pharm. 2013 Aug 1;70(15):1301-12. doi: 10.2146/ajhp130049. Am J Health Syst Pharm. 2013. PMID: 23867487 Free PMC article. Review.
Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose.
Ballesta Méndez M, van Pesch V, Capron A, Hantson P. Ballesta Méndez M, et al. Case Rep Neurol Med. 2014;2014:237064. doi: 10.1155/2014/237064. Epub 2014 Apr 17. Case Rep Neurol Med. 2014. PMID: 24822136 Free PMC article.
[4-Aminopyridine (Fampridine). A new attempt for the symptomatic treatment of multiple sclerosis].
Husseini L, Leussink VI, Kieseier BC, Hartung HP. Husseini L, et al. Nervenarzt. 2010 Feb;81(2):203-11. doi: 10.1007/s00115-009-2902-2. Nervenarzt. 2010. PMID: 20112006 Review. German.
Neuroprotective Properties of 4-Aminopyridine.
Dietrich M, Hartung HP, Albrecht P. Dietrich M, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Mar 2;8(3):e976. doi: 10.1212/NXI.0000000000000976. Print 2021 May. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33653963 Free PMC article. Review.
Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis.
Hayes KC. Hayes KC. Neuropsychiatr Dis Treat. 2011;7:229-39. doi: 10.2147/NDT.S10469. Epub 2011 Apr 28. Neuropsychiatr Dis Treat. 2011. PMID: 21573085 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information